Tobacco Does NOT Cause False-Positive Plasma Free Fractionated Metanephrines
Tobacco use is not listed as a cause of false-positive results on plasma free fractionated metanephrines testing. The Endocrine Society Clinical Practice Guidelines specifically identify medications and physiological conditions that interfere with metanephrine testing, and tobacco is notably absent from these lists 1.
Known Causes of False-Positive Results
The 2014 Endocrine Society guidelines explicitly identify the following causes of false-positive plasma metanephrine results 1:
Medications That Cause False-Positives:
- Tricyclic antidepressants (can cause mild to marked elevations, particularly normetanephrine - up to 40% higher with false-positive rates reaching 23%) 2
- Serotonin-norepinephrine reuptake inhibitors (SNRIs) (similar mechanism to tricyclics) 2
- Acetaminophen, mesalamine, sulfasalazine (direct interference with LC-ECD measurement methods) 1
- Midodrine (causes falsely elevated metanephrine through analytical interference) 3
- Alpha-1 blockers (associated with elevated urinary metanephrines) 4
Physiological Causes:
- Inappropriate sampling position - seated rather than supine position (most common cause of borderline false-positives) 1
- Physiological stress - particularly in intensive care settings 1
- Age - plasma normetanephrine increases with age, accounting for most false-positives in older patients 5
Critical Sampling Requirements
To minimize false-positives, the guidelines emphasize 1:
- Patient must be fully recumbent (supine) for at least 30 minutes before blood draw
- Seated sampling increases false-positive likelihood and requires follow-up supine sampling
- For dopamine metabolite (3-methoxytyramine) measurements, overnight fasting is required
Clinical Approach to Borderline Elevations
When results are borderline positive 1:
- First step: Repeat sampling in proper supine position (resolves most false-positives)
- If still elevated: Consider clonidine suppression test for normetanephrine
- Alternative confirmatory tests: Chromogranin A plus urinary fractionated metanephrines 6
- Wait-and-retest approach: For low clinical suspicion, repeat in 6+ months to detect tumor growth patterns
The absence of tobacco from comprehensive lists of interfering substances in authoritative guidelines indicates it does not cause false-positive results on this test.